AdaptVac Company
AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophylactic vaccines to treat and prevent specific cancers, infectious diseases and immunological disorders. AdaptVac is currently focused on developing a COVID-19 vaccine.
Technology:
COVID
Headquarters:
Denmark
Funding Status:
N/A
Investment Stage:
N/A
Founded Date:
N/A
Number Of Exists:
N/A
Employee Number:
N/A
Industry:
Vaccine/Drug
Investor Type:
N/A